European corporate earnings expectations improved again, according to LSEG I/B/E/S forecasts, as European blue-chip indices pushed to highs on a stronger-than-anticipated earnings season so far.
But the earnings picture remains negative. The current estimate is still for a 1.1% drop in fourth-quarter 2025 earnings for European companies on average, even after a substantial upgrade from last week’s expectation of a 3.1% decline. The same dataset still frames this as the weakest earnings performance in seven quarters.
One blunt sentence.
This is a relief rally built on revisions, not momentum.
The part professionals should take seriously is not the absolute number, but the direction and speed of the revisions. The forecast path described in the source is a story of sudden damage, then slow repair. After the announcement of plans for a wide array of tariffs by the U.S. president in February last year, market forecasts for fourth-quarter earnings sharply deteriorated. Expectations shifted from around 11% growth before that announcement to an estimated contraction that at its worst reached as much as 4.2% in January. That sequence matters because it tells you what the market has been doing: it has been lowering its bar aggressively, and then gradually discovering that companies can step over the lowered bar more often than expected. The upgrade from a 3.1% decline to a 1.1% decline is not a miraculous operational turnaround. It is the mechanical outcome of a reporting season that is, so far, beating expectations at a better-than-normal rate, with 60% of companies beating analyst estimates versus a typical 54%. That beat rate is doing the work of stabilizing sentiment. It also exposes the core tension: when the bar has been moved down quickly and repeatedly, a “better-than-anticipated season” can produce a strong sentiment response even if the underlying outcome remains an earnings contraction and still qualifies as the weakest performance in seven quarters.
“This wasn’t about growth. It was about the reset.”
The source is also blunt about where the optimism runs out: revenue expectations are deteriorating even as earnings expectations improve. STOXX 600 revenues are now expected to be 3.4% lower than the same period last year, worse than the 3.2% decline forecast a week earlier. That is the awkward tell. Earnings revisions can improve through cost discipline, mix shifts, and lower expectations, but revenue deterioration is harder to celebrate because it is closer to the demand and pricing reality companies are facing. In this setup, a rising beat rate alongside weakening revenue expectations suggests something specific: the corporate sector is navigating by managing the income statement more than expanding the top line. That is not inherently bad, but it is a different kind of “health” than the market typically pays up for. It can support confidence for a while, yet it tends to make the next phase of expectations more sensitive. If revenue keeps sliding, there is less room for companies to keep delivering upside surprises without either further cost action or a better pricing environment. The fact that the earnings season is better than anticipated while revenue forecasts deteriorate is the kind of divergence that makes professional investors stop repeating the headline and start reading the footnotes.
Sentiment, in the source, is not floating in the abstract. It is being carried by specific corporate signals: better-than-expected results from luxury group Hermes and Ray-Ban maker EssilorLuxottica, paired with positive guidance for 2026 from Anheuser-Busch InBev and Siemens. That list matters because it tells you what the market is choosing to reward right now. Hermes and EssilorLuxottica are read as demand resilience and pricing power stories in their own right, while AB InBev and Siemens offering positive 2026 guidance feeds a different appetite: visibility. In an environment where the broader outlook was damaged by tariff-related uncertainty and then slowly repaired through incremental beats, guidance becomes a substitute for macro confidence. The market isn’t only asking “what did you do last quarter.” It’s asking “can you tell me something steady about next year without sounding like you’re bluffing.” Those company signals are, in this story, acting as a scaffold for European investor sentiment and for the idea that the worst-case earnings path is being walked back.
“This was never one story. It’s a patchwork of survivals.”
Where expectations may still be misaligned is in what “improved outlook” actually means. The source uses the language of improvement and rebound, but it also anchors that improvement to a downward earnings outcome and to the weakest performance in seven quarters. That is not contradictory. It is just easy to misread. The professional read is narrower: the outlook improved relative to a recent pessimistic baseline, not relative to a healthy growth trajectory. When the market upgrades a forecast from a 3.1% decline to a 1.1% decline, the instinct is to treat it as a directional victory. It is. But it is also a reminder of how quickly the market’s confidence was damaged and how dependent the rebound is on incremental beats. A 60% beat rate versus 54% typical sounds comforting, but it is not a guarantee of sustained earnings momentum. It is a statistical description of a season so far. And it is happening alongside revenue forecasts that are deteriorating. That combination creates a specific kind of fragility: investors can feel “better” while the fundamentals remain constrained. If you want to understand why a region’s indices can hit highs while the earnings line remains negative, this is the mechanism. It is not euphoria. It is recalibration. It is the market rediscovering that the corporate sector is not collapsing as fast as feared, and deciding that “less bad” is worth paying for, at least temporarily. The risk is that “less bad” becomes an implicit growth narrative in people’s positioning, even when the dataset is telling you the opposite on both earnings (still down) and revenues (down more than previously thought). Professionals should not confuse a rebound in forecasts with a return to clean growth assumptions. The rebound is real, but it is not broad. And it is happening in a landscape already shaped by tariff-related uncertainty that pushed the earnings outlook from expected growth to meaningful contraction over the past year. When that kind of macro policy shock sits in the background, the market’s tolerance for disappointment tends to be lower, not higher.
The pressures, in this frame, fall into two buckets. The first is on corporate management teams: if the market is rewarding beats and guidance, the burden of precision rises. The second is on investors: when indices are hitting highs on the back of an upgraded-but-still-negative earnings path, positioning becomes more sensitive to any shift in revisions.
The source doesn’t give you sector breakdowns beyond the company references, so it would be a mistake to pretend we can map every pocket of strength and weakness. But it does offer a clue about what is carrying sentiment: luxury results that beat expectations and large-company guidance that sounds constructive for 2026. That is a narrow bridge, not a broad highway.
“This wasn’t a turnaround. It was a re-rating of survival.”
There is also a second-order implication embedded in the revenue line that professionals tend to underestimate. When revenue expectations deteriorate even as earnings expectations rebound, the market is implicitly leaning on margin resilience. That can hold for a period, but it is not an infinite resource. The moment the market believes margin defense is getting harder, the same revision mechanism that improved the outlook can reverse quickly. The source has already shown how quickly forecasts can deteriorate when a macro policy shock hits, and how the earnings expectation moved from double-digit growth to contraction as deep as 4.2% in estimates. That history matters because it shows that the consensus is not stable. It is reactive. If that’s the regime, professionals should be less interested in celebrating a one-week improvement and more interested in monitoring whether the revisions are now becoming a trend or just a bounce.
The best signal in the source is almost embarrassingly simple: the market is healing its own narrative, one earnings report at a time, but the underlying numbers remain constrained enough that any new shock could drag the conversation back to downside.
By Fouad Gibran
